Curidium Medica plc Announces Presentation at Conference

London, UK, 31 October 2007, Curidium Medica plc, (LSE: CUR) the personalized medicine company focused on bringing the right drug to the right patient, today announced that Gosse B. Bruinsma M.D., Executive Chairman, will be presenting at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New York, New York, USA. The presentation is scheduled at 4:25 pm Eastern time on Tuesday, 6 November 2007 in the New York Palace Hotel. Dr. Bruinsma’s presentation will be webcast and is accessible remotely by persons wishing to follow the presentation live and will be archived for 90 days; for access please visit: http://www.rodmanandrenshaw.com/conferences.

MORE ON THIS TOPIC